Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Woodcock To Be Acting US FDA Commissioner, Leaving Agency in Stable, Capable Hands

Woodcock_Janet_1200x675

Related Content

Sharfstein: US FDA Incentives Not Broke, But Fix Them

Jan 15 2020

A Return Trip For Kessler At US FDA? It Wouldn’t Be The First Time It’s Happened

Dec 03 2020

Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue

Nov 24 2020

US FDA Faces Succession Questions As Hahn’s Departure Nears

Jan 06 2021

Plasma Authorization Raises Fears Of Politically-Influenced COVID-19 Vaccine Decisions, Compromised FDA

Aug 25 2020

FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit

Jan 17 2011

COVID-19 Staff Shakeup: Woodcock Moves to Commissioner's Office As Marks Drops Out Of 'Warp'

May 23 2020

Additional Topics

United States FDA Leadership Elections Coronavirus COVID-19 Politics Policy Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window